MedPath

Northwestern University Human Resources

Northwestern University Human Resources logo
🇺🇸United States
Ownership
Private
Established
1851-01-28
Employees
5K
Market Cap
-
Website
https://www.venturecat.northwestern.edu

Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma

Phase 1
Terminated
Conditions
Stage IA Mycosis Fungoides/Sezary Syndrome
Stage I Cutaneous T-cell Non-Hodgkin Lymphoma
Stage IIB Mycosis Fungoides/Sezary Syndrome
Recurrent Mycosis Fungoides/Sezary Syndrome
Stage IVB Mycosis Fungoides/Sezary Syndrome
Stage IIA Mycosis Fungoides/Sezary Syndrome
Stage IIIB Mycosis Fungoides/Sezary Syndrome
Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
Stage IB Mycosis Fungoides/Sezary Syndrome
Interventions
Drug: carfilzomib
Drug: romidepsin
Other: laboratory biomarker analysis
First Posted Date
2012-11-30
Last Posted Date
2019-08-29
Lead Sponsor
Northwestern University
Target Recruit Count
7
Registration Number
NCT01738594
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Microbiomes of Pelvic Pain

Completed
Conditions
Chronic Pelvic Pain Syndrome
Interstitial Cystitis
Chronic Prostatitis
Lower Urinary Tract Symptoms
Major Depression
Overactive Bladder
First Posted Date
2012-11-30
Last Posted Date
2024-04-24
Lead Sponsor
Northwestern University
Target Recruit Count
91
Registration Number
NCT01738464
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions

Early Phase 1
Withdrawn
Conditions
Actinic Keratosis
Interventions
Procedure: cryotherapy
Drug: Ingenol mebutate
First Posted Date
2012-11-28
Last Posted Date
2021-12-06
Lead Sponsor
Northwestern University
Registration Number
NCT01735942

Combination of Ultrasound Treatment and Neck Liposuction for Skin Tightening

Not Applicable
Withdrawn
Conditions
Skin Laxity
Interventions
Procedure: Sham Treatment
Procedure: Neck Liposuction and Ultrasound Treatment
First Posted Date
2012-11-28
Last Posted Date
2021-12-06
Lead Sponsor
Northwestern University
Registration Number
NCT01735929

Cabergoline in Metastatic Breast Cancer

Early Phase 1
Completed
Conditions
Recurrent Breast Cancer
Stage IV Breast Cancer
Interventions
First Posted Date
2012-11-21
Last Posted Date
2019-09-17
Lead Sponsor
Northwestern University
Target Recruit Count
20
Registration Number
NCT01730729
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

Consumer Understanding and Use of Medication Guides

Completed
Conditions
Revised Medication Guide Formats
First Posted Date
2012-11-21
Last Posted Date
2014-04-09
Lead Sponsor
Northwestern University
Target Recruit Count
600
Registration Number
NCT01731405
Locations
🇺🇸

Primary Care Plus, Chicago, Illinois, United States

🇺🇸

Northwestern Medical Faculty Foundation, Chicago, Illinois, United States

The Use of Tranexamic Acid to Reduce Perioperative Blood Loss During High Risk Spine Fusion Surgery

Phase 2
Completed
Conditions
Curvature of Spine
Interventions
First Posted Date
2012-11-20
Last Posted Date
2021-01-26
Lead Sponsor
Northwestern University
Target Recruit Count
61
Registration Number
NCT01728636
Locations
🇺🇸

Northwestern Memorial Hospital, Chicago, Illinois, United States

Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase

Early Phase 1
Active, not recruiting
Conditions
Drug Safety
Interventions
First Posted Date
2012-11-07
Last Posted Date
2024-02-05
Lead Sponsor
Northwestern University
Target Recruit Count
5
Registration Number
NCT01722916
Locations
🇺🇸

Northwestern University Department of Dermatology, Chicago, Illinois, United States

Study of Skin and Muscle Parameters Using a Skin Sensor

Not Applicable
Completed
Conditions
Skin Wounds
Interventions
Device: Skin sensor
First Posted Date
2012-11-07
Last Posted Date
2021-12-06
Lead Sponsor
Northwestern University
Target Recruit Count
4
Registration Number
NCT01722929
Locations
🇺🇸

Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring

Phase 4
Completed
Conditions
Atrial Fibrillation
Interventions
Drug: Non-coumadin Oral Anticoagulant
First Posted Date
2012-10-15
Last Posted Date
2016-03-23
Lead Sponsor
Northwestern University
Target Recruit Count
59
Registration Number
NCT01706146
Locations
🇨🇦

University of Western Ontario, London, Ontario, Canada

🇺🇸

Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath